The Effectiveness of Augmented Reality Facilitated Education in Promoting Care Management of Malignant Fungating Wounds Among Oncology Nurses
1 other identifier
interventional
188
1 country
1
Brief Summary
Malignant fungating wounds (MFWs) affect 5-14% of patients with advanced cancer, making them a common complication in this population. Characterized by symptoms such as foul odor, heavy exudate, bleeding, moderate to severe pain, and infection, MFWs cause significant physical discomfort and pose life-threatening risks while also leading to profound psychosocial issues, including shame and social isolation. These factors severely impact patients' quality of life, with half of those diagnosed surviving only six months on average. However, clinical nursing staff often lack adequate knowledge and skills in managing MFWs, with an average accuracy rate of just 56.5%. Notable deficiencies exist in areas such as wound disinfection, odor control, and wound assessment, directly affecting the quality of patient care and highlighting an urgent need for specialized MFW training. Traditional MFW education often lacks real-life clinical scenarios and hands-on practice, resulting in a gap between learning and application and leaving learners ill-prepared for the complexities of clinical settings. In contrast, augmented reality (AR) technology presents new possibilities for nursing education. AR can create highly simulated clinical environments where learners can safely practice complex clinical skills, enhancing clinical decision-making abilities. The implementation of AR-based training programs provides nursing staff with a more realistic and effective learning experience, allowing them to better address the challenges posed by MFWs and ultimately contributing to improvements in patient care and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
March 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedDecember 31, 2025
February 1, 2025
7 months
December 24, 2024
December 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
MFWs care Knowledge scale
1\. \*\*MFWs Care Knowledge Scale\*\* This study will assess MFWs care knowledge using the \*\*MFWs Care Knowledge Scale\*\*. The scale ranges from \*\*0 to 100\*\*, with higher scores indicating \*\*better\*\* knowledge levels. The assessment will be conducted at \*\*baseline and post-intervention\*\* to measure changes in MFWs care knowledge over time.
6months
Secondary Outcomes (1)
Clinical Reasoning Scale
6months
Study Arms (2)
Augmented Reality
EXPERIMENTALParticipants in the experimental group will receive an introduction to updated malignant fungating wound (MFWs) care guidelines and clinical applications, covering essential topics such as evidence-based wound management techniques, odor control, exudate handling, bleeding prevention, and pain management. Training will also address the identification and management of common MFWs-related complications, including infection. Additionally, participants will utilize the "MFWs with AR" program, engaging in simulated scenarios to enhance clinical reasoning and decision-making skills.
Classroom Teaching
PLACEBO COMPARATORClassroom Teaching and Case Sharing Introduction to Updated MFWs Care Guidelines and Clinical Applications MFWs Wound Care Management of Common MFWs-Related Complications
Interventions
MFWs with AR This study utilized MyWeb AR as the primary development platform to create an AR-enhanced teaching curriculum for malignant fungating wound (MFW) care. Based on the 2022 Clinical Care Guidelines for Malignant Fungating Wounds and expert input from oncology specialists, the content covers key aspects of MFW care, including wound assessment, symptom identification, and care principles such as odor control, exudate management, and infection prevention. The program uses 3D object elements and animations to create interactive AR scenarios, allowing participants to engage in simulated clinical decision-making and care management, thereby enhancing their skills in a safe and controlled environment.
Classroom Teaching and Case Sharing Introduction to Updated MFWs Care Guidelines and Clinical Applications MFWs Wound Care Management of Common MFWs-Related Complications Case Sharing on MFWs Complication Management: Researchers
Eligibility Criteria
You may qualify if:
- Full-time nursing staff working in oncology wards at a teaching hospital in northern Taiwan
- Individuals willing to participate in the study and who have signed the informed consent form
You may not qualify if:
- Nursing staff not assigned to oncology-related wards
- Individuals expected to be unable to complete full participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MacKay Memorial Hosital
New Taipei City, New Taipei City, 251404, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2024
First Posted
March 28, 2025
Study Start
August 1, 2024
Primary Completion
March 12, 2025
Study Completion (Estimated)
October 1, 2026
Last Updated
December 31, 2025
Record last verified: 2025-02